The role of NF-kappa B and NF-IL6 transactivating factors in the synergistic activation of human serum amyloid A gene expression by interleukin-1 and interleukin-6.

This publication has 42 references indexed in Scilit:

• p105 and p98 precursor proteins play an active role in NF-kappa B-mediated signal transduction.
  Genes & Development, 1993
• Analysis of the Genomic and Derived Protein Structure of a Novel Human Serum Amyloid A Gene, SAA4
  Scandinavian Journal of Immunology, 1992
• B cell lymphoma-associated chromosomal translocation involves candidate oncogene lyt-10, homologous to NF-κB p50
  Cell, 1991
• Constitutive and NF-κB—like proteins in the regulation of the serum amyloid a gene by interleukin 1
  Cytokine, 1991
• The v-rel oncogene encodes a κB enhancer binding protein that inhibits NF-κB function
  Cell, 1990
• The DNA binding subunit of NF-κB is identical to factor KBF1 and homologous to the rel oncogene product
  Cell, 1990
• Glucocorticosteroid‐dependent synergy between interleukin 1 and interleukin 6 for human B lymphocyte differentiation
  European Journal of Immunology, 1988
• Action of recombinant human interleukin 6, interleukin 1β and tumor necrosis factor α on the mRNA induction of acute‐phase proteins
  European Journal of Immunology, 1988
• Synergistic activation of human t cells by interleukin 1 and interleukin 6
  European Journal of Immunology, 1988
• Interferon γ and lymphotoxin or tumor necrosis factor act synergistically to induce macrophage killing of tumor cells and schistosomula of schistosoma mansoni
  The Journal of Experimental Medicine, 1987